Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...

"Because I had waited so long, the infection had spread to my bloodstream and now my organs had begun to fail." ...

Millions of people in the world today face starvation in Gaza and in other parts of the world, from Sudan to Yemen. What ...